Accumen completed the acquisition of 3DR Laboratories.

Arsenal Capital-backed Accumen, a healthcare transformation company, completed the acquisition of 3DR Laboratories, which provides services to several hospitals, radiology practices, and independent imaging centers. Financial terms were not disclosed. The addition of 3DR Laboratories to the Accumen portfolio of companies brings expansion to Accumen’s clinical offerings, as well as depth to its imaging transformation offering, which is focused on operational performance in imaging departments and centers across the country bringing meaningful savings, operational efficiencies and improved patient care. “We are delighted that 3DR Laboratories is joining our Clinical Performance Business Unit and further strengthening our imaging transformation service line. We are very impressed with the high quality and consistency of 3DR’s computed tomography and magnetic resonance imaging (MRI) post-processing work, as well as its strong service-centric reputation which is enabling radiologists to meet even the most urgent patient needs,” Jeff Osborne, Accumen President and CEO.